Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05219955 · ClinicalTrials.gov registry record · NA
Caregiver Stress and Sleep Study
A NA study of Depressive Symptoms and Caregiver Burden, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05219955: Recruiting NA study of Depressive Symptoms and Caregiver Burden, sponsored by University of Pittsburgh.
NCT05219955 is a NA study of Depressive Symptoms and Caregiver Burden that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 120 participants, below the 260-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05219955, a NA study of Depressive Symptoms and Caregiver Burden, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study includes a randomized experimental component where therapists will systematically deliver an experimental behavioral probe or a supportive control condition. The aim is to evaluate effects on meaningful health-relevant measures including morning activation levels, depression symptoms, rumination, and aspects brain connectivity previously linked with depression.
Primary Outcome
Rumination will be measured using the rumination subscale of the Behavioral Activation Scale for Depression (BASD). There is a minimum possible score of 0 and a maximum possible score of 24 with higher scores indicating higher \[worse\] rumination. This measure will be accessed via Ecological Momentary Assessment (EMA). A link will be sent to participant's mobile device by text message cuing participants to respond
Conditions Studied
Interventions
- BEHAVIORAL Morning Action Plan Execution
- BEHAVIORAL Activity Strategy-based Session with Therapist
- BEHAVIORAL Attention-based Session with Therapist
- BEHAVIORAL Advance sleep-wake time
Study Locations (1)
Pennsylvania
- UPMC Western Behavioral Health - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05219955 shows while recruiting
NCT05219955 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 260-participant average among 60 other Depressive Symptoms trials with a reported enrollment target (54% lower).
The record links to 2 conditions, with Depressive Symptoms appearing as the primary indexed condition, and to 4 interventions - of which Morning Action Plan Execution is the first listed.
NCT05219955 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05219955 about?
NCT05219955 is a clinical study titled "Caregiver Stress and Sleep Study". This study includes a randomized experimental component where therapists will systematically deliver an experimental behavioral probe or a supportive control condition. The aim is to evaluate effects on meaningful health-relevant measures including morning activation levels, depression symptoms, rum...
What is the current status of trial NCT05219955?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-07-15. Estimated completion is 2026-12.
What conditions does trial NCT05219955 study?
This clinical trial studies the following conditions: Depressive Symptoms, Caregiver Burden.
What interventions are being tested in trial NCT05219955?
The interventions under investigation include: Morning Action Plan Execution (BEHAVIORAL), Activity Strategy-based Session with Therapist (BEHAVIORAL), Attention-based Session with Therapist (BEHAVIORAL), Advance sleep-wake time (BEHAVIORAL).
Who is sponsoring clinical trial NCT05219955?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05219955 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05219955's enrollment target sits among peer trials
120 25th of 60 higher than 34 of 60 other Depressive Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Mood and Thought Process Study
RECRUITING · NA
-
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
RECRUITING · NA
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)
RECRUITING · NA
-
Family Spirit Strengths
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI